Home › Von Hippel-Lindau Disease › Massachusetts
Von Hippel-Lindau Disease clinical trials in Massachusetts
3 studies for Von Hippel-Lindau Disease are looking for participants at sites in Massachusetts.
Cities in Massachusetts
Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
- Massachusetts General Hospital ( Site 0111), Boston
RecruitingPhase 2
Ages 12 and older · All sexes · Updated Sep 25, 2026 · NCT04924075Extension Study for Participants in Studies That Include Belzutifan (MK-6482-043/LITESPARK-043)
- Beth Israel Deaconess Medical Center ( Site 0107), Boston
- Dana-Farber Cancer Institute ( Site 0105), Boston
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT07405164MyVHL: Patient Natural History Study
- VHL Alliance, Boston
RecruitingObservational studyHealthy volunteers welcome
All ages · All sexes · Updated Apr 26, 2024 · NCT03749980From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.